ARTICLE
17 March 2014

Drug Companies Are Reminded - FDA Is Following Facebook

The FDA’s Office of Prescription Drug Promotion has warned a Swiss drug company about statements the company made on its Facebook page.
United States Food, Drugs, Healthcare, Life Sciences

Our Life Sciences Legal Update blog reports today that the FDA's Office of Prescription Drug Promotion has warned a Swiss drug company about statements the company made on its Facebook page, suggesting that consumers talk to their doctor about a drug without disclosing the risks associated with the product (risks serious enough to require a boxed warning on the label). The FDA action is a reminder that that FDA's advertising and promotion rules apply regardless of how or where the product is promoted, and the FDA is monitoring social media sites for such activities. For more information, see the full post.

This article is presented for informational purposes only and is not intended to constitute legal advice.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More